Glaucoma Treatment Study
Clinical evaluation of the SOLX Gold Shunt for the reduction of intraocular pressure (IOP) in refractory glaucoma
Netland Peter, A
IRB-HSR # 15259: SOLX Gold Shunt for Refractory Glaucoma The purpose of this study is to establish the clinical performance of the investigational device, the SOLX Gold Shunt for its ability to decrease intraocular pressure (IOP) in eyes with refractory glaucoma where medical and conventional surgical treatments have failed. Key Eligibility Criteria: 1. At least 21 years of age 2. Diagnosis of primary open-angle glaucoma in the potential study eye 3. Refractory glaucoma in the study eye (defined as having elevated IOP while on maximally tolerated IOP-lowering medications and having undergone a prior conventional glaucoma surgical intervention) 4. Intraocular pressure e 24 mmHg For more information about this study please contact the Clinical Research Coordinator, Kristina Holbrook, at (434) 243-2852 or email@example.com . The principal investigator is Peter A. Netland, M.D., Ph.D.